Review Article
PPAR Inhibitors as Novel Tubulin-Targeting Agents
Table 1
Effects of PPARγ inhibitors on PPARγ, PPARα, and PPARδ activity IC50 (nM) for ability to compete with a PPAR agonist.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(1)GW9662 is also a partial activator of PPARα with an EC50 of 22 nM [8], leading to the apparently higher concentrations
of GW9662 required to inhibit PPARα than would be predicted by the direct
binding assay.(2)Dose curves were not performed, but the indicated concentrations
suppressed the GAL4 chimera as indicated. |